Carmine joined NVM in 2018 and is responsible for identifying investment opportunities in the North West and Wales, progressing NVM’s investments from origination, and supporting portfolio companies as they grow. Prior to this, he was at the Development Bank of Wales’ technology venture team where he invested in early-stage businesses. He has a First-class BSc honours degree in Pharmacology with Industrial Experience and a PhD in Cardiovascular Medicine from the University of Manchester. Carmine joined Mercia in December 2019 when NVM’s VCTs contracts were acquired by Mercia.